Tag: ANGPTL8

Recombinant Human Angiopoietin-Like Protein 8/ANGPTL8/Betatrophin (C-6His)

Recombinant Human Angiopoietin-Like Protein 8/ANGPTL8/Betatrophin (C-6His) | Scientist.com Skip to Main Content Go to Main Navigation Details Alternative Name: Betatrophin,Angiopoietin-like protein 8,Lipasin,Angptl8 Amino Acid: Recombinant Human Angiopoietin-like protein 8 is produced by our E.coli expression system and the target gene encoding Ala22-Ala198 is expressed with a 6His tag at the…

Continue Reading Recombinant Human Angiopoietin-Like Protein 8/ANGPTL8/Betatrophin (C-6His)

Adolescent Obesity and ANGPTL8: Correlations with High Sensitivity C-reactive Protein, Leptin, and Chemerin

1Kuwait University, Kuwait 2Dasman Diabetes Institute, Kuwait The final, formatted version of the article will be published soon. Notify me Receive an email when it is updated You just subscribed to receive the final version of the article Angiopoietin-like proteins (ANGPTLs)…

Continue Reading Adolescent Obesity and ANGPTL8: Correlations with High Sensitivity C-reactive Protein, Leptin, and Chemerin

Correlation Between the Levels of ANGPTL3, ANGPTL4, ANGPTL8 and Postpr

Introduction As the prevalence of hyperlipidemia has increased, the assessment of blood lipids is increasingly important.1 At present, fasting lipid indices, including total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C) levels are most commonly assessed in clinical practice.2 Among them, the TG level is one of the most…

Continue Reading Correlation Between the Levels of ANGPTL3, ANGPTL4, ANGPTL8 and Postpr

Emerging Insights into the Roles of ANGPTL8 Beyond Glucose and Lipid Metabolism

1Affiliated Hospital of Qinghai University, China The final, formatted version of the article will be published soon. Notify me Receive an email when it is updated You just subscribed to receive the final version of the article Angiopoietin-like protein 8 (ANGPTL8) is a…

Continue Reading Emerging Insights into the Roles of ANGPTL8 Beyond Glucose and Lipid Metabolism

ANGPTL8 blockade with a monoclonal antibody promotes triglyceride clearance, energy expenditure, and weight loss in mice

ANGPTL8 blockade with a monoclonal antibody promotes triglyceride clearance, energy expenditure, and weight loss in mice – Fingerprint — University of Texas Southwestern Medical Center Sort by Weight Alphabetically Medicine & Life Sciences Energy Metabolism 100% Weight Loss 91% Triglycerides 88% Monoclonal Antibodies 80% Lipoprotein Lipase 66% Body Weight 59%…

Continue Reading ANGPTL8 blockade with a monoclonal antibody promotes triglyceride clearance, energy expenditure, and weight loss in mice

(PDF) Angiopoietin-like protein 8 (ANGPTL8)/betatrophin overexpression does not increase beta cell proliferation in mice | Julia Chavez

(PDF) Angiopoietin-like protein 8 (ANGPTL8)/betatrophin overexpression does not increase beta cell proliferation in mice | Julia Chavez – Academia.edu Academia.edu uses cookies to personalize content, tailor ads and improve the user experience. By using our site, you agree to our collection of information through the use of cookies. To learn…

Continue Reading (PDF) Angiopoietin-like protein 8 (ANGPTL8)/betatrophin overexpression does not increase beta cell proliferation in mice | Julia Chavez

ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance

ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance – Fingerprint — University of Texas Southwestern Medical Center Sort by Weight Alphabetically Chemical Compounds Lipoprotein 91% Clearance 89% Triglyceride 87% Plasma 50% Protein 13% Medicine & Life Sciences Lipoprotein Lipase 100% Triglycerides 66% Angiopoietins 23% Blocking Antibodies 19%…

Continue Reading ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance

IJMS | Free Full-Text | Increased Levels of Circulating IGFBP4 and ANGPTL8 with a Prospective Role in Diabetic Nephropathy

Int. J. Mol. Sci. 2023, 24(18), 14244; doi.org/10.3390/ijms241814244 (registering DOI) Int. J. Mol. Sci. 2023, 24(18), 14244; doi.org/10.3390/ijms241814244 (registering DOI) Received: 27 July 2023 / Revised: 17 August 2023 / Accepted: 14 September 2023 / Published: 18 September 2023 Round 1 Reviewer 1 Report 1. What was the criteria of DN diagnosis?…

Continue Reading IJMS | Free Full-Text | Increased Levels of Circulating IGFBP4 and ANGPTL8 with a Prospective Role in Diabetic Nephropathy

Metabolites | Free Full-Text | Targeted Metabolomics Analysis of Individuals Carrying the ANGPTL8 R59W Variant

The role of ANGPTL8 in metabolizing lipids and glucose and in metabolic disorders and inflammation is widely recognized [7,8,9,27,44,45,46]. The rs2278426, while a missense (R59W) variant in ANGPTL8, is located in the intron in the DOCK6 gene. The variant downregulates CTC-510F12.4 (a novel transcript) in whole blood, upregulates DOCK6 in…

Continue Reading Metabolites | Free Full-Text | Targeted Metabolomics Analysis of Individuals Carrying the ANGPTL8 R59W Variant

New Hepatokine Discovery Offers Hope for Treatment of Hypertriglyceridemia

PRESS RELEASE Published July 10, 2023 “A groundbreaking research paper published in the journal Science Signaling has identified a new hepatokine that promotes triglyceride metabolism” The research was led by Kezhong Zhang, Ph.D., Professor at the Center for Molecular Medicine and Genetics and the Department of Biochemistry, Microbiology, and Immunology…

Continue Reading New Hepatokine Discovery Offers Hope for Treatment of Hypertriglyceridemia

Association between ANGPTL3, 4, 8 and CVRF in HTN

Fangfang Xu,1,* Lijun Shen,2,* Yongguang Yang,2 Limin Kong,3 Wufan Zu,4 Dandan Tian,5 Xuanchao Cao,1 Gairong Huang1 1Key Laboratory of Geriatrics, Institute of Geriatrics, Department of Geriatric Medicine, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China; 2Department of Clinical Medical Research Center, Henan Provincial People’s…

Continue Reading Association between ANGPTL3, 4, 8 and CVRF in HTN

Plasma ANGPTL8 Levels and Risk for Secondary Cardiovascular Events in Japanese Patients With Stable Coronary Artery Disease Receiving Statin Therapy

Background: The ability to predict secondary cardiovascular events could improve health of patients undergoing statin treatment. Circulating ANGPTL8 (angiopoietin-like protein 8) levels, which positively correlate with proatherosclerotic lipid profiles, activate the pivotal proatherosclerotic factor ANGPTL3. Here, we assessed potential association between circulating ANGPTL8 levels and risk of secondary cardiovascular events…

Continue Reading Plasma ANGPTL8 Levels and Risk for Secondary Cardiovascular Events in Japanese Patients With Stable Coronary Artery Disease Receiving Statin Therapy

Dual role of ANGPTL8 in promoting tumor cell proliferation and immune escape during hepatocarcinogenesis

The interplay between hepatocellular carcinoma (HCC) cells and the tumor microenvironment is essential for hepatocarcinogenesis, but their contributions to HCC development are incompletely understood. We assessed the role of ANGPTL8, a protein secreted by HCC cells, in hepatocarcinogenesis and the mechanisms through which ANGPTL8 mediates crosstalk between HCC cells and…

Continue Reading Dual role of ANGPTL8 in promoting tumor cell proliferation and immune escape during hepatocarcinogenesis

TDAG51 Attenuates Impaired Lipid Metabolism and Insulin Resistance in Gestational Diabetes Mellitus Through SREBP-1/ANGPTL8 Pathway

Background: T-cell death-associated gene 51 (TDAG51) belongs to the transcription factor family and is involved in the energy homeostasis of the liver through the regulation of lipogenesis. Aims: To evaluate the role of T-cell death-associated gene 51 in gestational diabetes mellitus. Study design: Experimental study. Methods: A total of 30…

Continue Reading TDAG51 Attenuates Impaired Lipid Metabolism and Insulin Resistance in Gestational Diabetes Mellitus Through SREBP-1/ANGPTL8 Pathway

JCM | Free Full-Text | Circulating ANGPTL8 as a Potential Protector of Metabolic Complications in Patients with Psoriasis

1. Introduction Psoriasis is a common, chronic, stigmatizing and still incurable skin disease, affecting 2% to 4% of the world’s population [1,2]. In the past, it was considered an exclusively dermatological and rheumatic disease, affecting the skin, nails and joints. Since 2000, research into the still-unknown pathogenesis of psoriasis has…

Continue Reading JCM | Free Full-Text | Circulating ANGPTL8 as a Potential Protector of Metabolic Complications in Patients with Psoriasis

Sci-Hub | ANGPTL8/Betatrophin R59W variant is associated with higher glucose level in non-diabetic Arabs living in Kuwaits. Lipids in Health and Disease, 15(1)

Sci-Hub | ANGPTL8/Betatrophin R59W variant is associated with higher glucose level in non-diabetic Arabs living in Kuwaits. Lipids in Health and Disease, 15(1) | 10.1186/s12944-016-0195-6 ◂ ↓ save Abu-Farha, M., Melhem, M., Abubaker, J., Behbehani, K., Alsmadi, O., & Elkum, N. (2016). ANGPTL8/Betatrophin R59W variant is associated with higher glucose…

Continue Reading Sci-Hub | ANGPTL8/Betatrophin R59W variant is associated with higher glucose level in non-diabetic Arabs living in Kuwaits. Lipids in Health and Disease, 15(1)

ANGPTL8 Recombinant Protein (Mouse) (OPCA03054) | Aviva Systems Biology

ANGPTL8 Recombinant Protein (Mouse) (OPCA03054) | Aviva Systems Biology | Aviva Systems Biology The store will not work correctly in the case when cookies are disabled. JavaScript…

Continue Reading ANGPTL8 Recombinant Protein (Mouse) (OPCA03054) | Aviva Systems Biology

Effect of physical activity in a weight loss program on circulating total ANGPTL8 concentrations in northern Americans with obesity: a prospective randomized controlled trial

Effect of physical activity in a weight loss program on circulating total ANGPTL8 concentrations in northern Americans with obesity: a prospective randomized controlled trial Abstract Background and Aims The primary goals of this study were to clarify 1) the effect of weight loss by lifestyle intervention on circulating total angiopoietin-like…

Continue Reading Effect of physical activity in a weight loss program on circulating total ANGPTL8 concentrations in northern Americans with obesity: a prospective randomized controlled trial

Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer

Sampson, J. N. et al. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types. J. Natl Cancer Inst. 107, djv279 (2015). PubMed  PubMed Central  Article  CAS  Google Scholar  Bosse, Y. & Amos, C. I. A decade of GWAS results in lung cancer. Cancer Epidemiol….

Continue Reading Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer

Kyttaro, Lilly sign licence agreement for monoclonal antibody programme

Low magnification micrograph of the distal right coronary artery with complex atherosclerosis and luminal narrowing. Credit: Nephron / commons.wikipedia.org. Kyttaro has signed an agreement to obtain an exclusive global licence for Eli Lilly and Company’s anti-angiopoietin-like (ANGPTL) 3/8 monoclonal antibody programme to treat atherosclerotic cardiovascular disease (ASCVD). The antibody will…

Continue Reading Kyttaro, Lilly sign licence agreement for monoclonal antibody programme

Liver-specific knockdown of ANGPTL8 alters the structure of the gut microbiota in mice | Annals of Microbiology

Bacterial taxonomic profiling of the gut microbiota from between controls and sh-ANGPTL8. a Relative abundance of the top 10 abundant bacterial phyla in indicated individuals. b, c Heat map of the top 10 abundant bacterial phyla in indicated individuals (b) and T test results (c). d Relative abundance of Bacteroidetes….

Continue Reading Liver-specific knockdown of ANGPTL8 alters the structure of the gut microbiota in mice | Annals of Microbiology

The Potential of ANGPTL8 Antagonism to Simultaneously Reduce Triglyceride and Increase HDL-Cholesterol Plasma Levels

Elevated triglyceride (TG) and reduced high-density lipoprotein-cholesterol (HDL-C) plasma levels are risk factors for atherosclerosis and cardiovascular disease. Therefore, a drug that simultaneously reduces TG and increases HDL-C plasma levels has the potential to prevent and treat these diseases. Angiopoietin-like 3 (ANGPTL3) regulates plasma TG and HDL-C levels by inhibiting…

Continue Reading The Potential of ANGPTL8 Antagonism to Simultaneously Reduce Triglyceride and Increase HDL-Cholesterol Plasma Levels